Description: Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Home Page: www.abbott.com
100 Abbott Park Road
North Chicago,
IL
60064-6400
United States
Phone:
224 667 6100
Officers
Name | Title |
---|---|
Mr. Robert B. Ford | Chairman of the Board, President & CEO |
Mr. Philip P. Boudreau | CFO & Executive VP of Finance |
Mr. Hubert L. Allen J.D. | Executive VP, General Counsel & Secretary |
Mr. Daniel Gesua Sive Salvadori | Executive VP and Group President of Established Pharmaceuticals & Nutritional Products |
Ms. Lisa D. Earnhardt | Executive VP & Group President of Medical Devices |
Ms. Sabina Ewing | Senior VP of Business & Technology Services and Chief Information Officer |
Mr. Michael Comilla | Vice President of Investor Relations. |
Erica L. Battaglia | VP and Chief Ethics & Compliance Officer |
Ms. Mary K. Moreland | Executive Vice President of Human Resources |
Ms. Melissa Brotz | Senior Vice President of Global Marketing & External Affairs |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
GIC Sector: | Health Care |
---|---|
GIC Group: | Health Care Equipment & Services |
GIC Industry: | Health Care Equipment & Supplies |
GIC Sub-Industry: | Health Care Equipment |
Forward PE: | 22.3714 |
---|---|
Trailing PE: | 35.0032 |
Price-to-Book MRQ: | 5.0222 |
Price-to-Sales TTM: | 4.6272 |
IPO Date: | |
Fiscal Year End: | December |
Full Time Employees: | 114000 |